Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Guillaume Pfefer, Ph.D., Kala’s President and Chief Executive Officer, is scheduled to present at the Targeting Ocular Disorders Conference being held September 26-27, 2013 in Boston, MA. The presentation, entitled “Breakthrough Solutions for Ocular Disease’ will take place on Thursday, September 26, 2013 at 3:30 p.m. ET during the Science for Success session.
Help employers find you! Check out all the jobs and post your resume.
